PRE Q4 2024 Earnings — Prenetics Global Limited Revenue & Financial Results | Market Cap Arena

PREPrenetics Global Limited

$287M

Q4 2024 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$10M+98.7% YoY

Gross Profit

$4M37.2% margin

Operating Income

-$17M-158.0% margin

Net Income

-$16M-155.8% margin

EPS (Diluted)

$-1.29

QoQ Revenue Growth

+34.8%

Cash Flow

Operating Cash Flow

$0

Free Cash Flow

$0

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$214M

Total Liabilities

$42M

Stockholders' Equity

$170M

Cash & Equivalents

$52M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$10M	$5M	+98.7%
Gross Profit	$4M	$3M	+50.3%
Operating Income	-$17M	-$11M	-44.5%
Net Income	-$16M	-$17M	+3.6%